Hypercalcemia Treatment Market to Approach US$ 25,230.2 Mn by 2026 : Pfizer Inc., Amgen Inc., Novartis AG, Dr. Reddy's Laboratories Ltd. and Cipla Inc
Hospitals distribution channel segment is projected to generate comparatively high revenue owing to novel and easy availability of hypercalcemia treatment drugs worldwide.
View full press release